User profiles for David Klatzmann
 | David KlatzmannSorbonne University & Pitié-Salpêtrière Hospital Verified email at sorbonne-universite.fr Cited by 39476 |
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
D Klatzmann, E Champagne, S Chamaret, J Gruest… - Nature, 1984 - nature.com
Many viruses, including retroviruses, are characterized by their specific cell tropism 1–3 .
Lymphadenopathy-associated virus (LAV) is a human lymphotropic retrovirus isolated from …
Lymphadenopathy-associated virus (LAV) is a human lymphotropic retrovirus isolated from …
Isolation of a new human retrovirus from West African patients with AIDS
…, C Dauguet, C Katlama, C Rouzioux, D Klatzmann… - Science, 1986 - science.org
The etiological agent of AIDS, LAV/HTLV-III, is common in Central Africa but is not endemic
in other areas of that continent. A novel human retrovirus, distinct from LAV/HTLV-III, has now …
in other areas of that continent. A novel human retrovirus, distinct from LAV/HTLV-III, has now …
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes
D Klatzmann, F Barré-Sinoussi, MT Nugeyre… - Science, 1984 - science.org
Lymphadenopathy associated virus (LAV) has been isolated from patients with the acquired
immunodeficiency syndrome (AIDS) or lymphadenopathy syndrome. Since the immune …
immunodeficiency syndrome (AIDS) or lymphadenopathy syndrome. Since the immune …
[HTML][HTML] Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis
…, D Sene, P Cacoub, D Klatzmann - … England Journal of …, 2011 - Mass Medical Soc
Background Patients with vasculitis induced by the hepatitis C virus (HCV) have reduced levels
of regulatory T cells (Tregs). Resolution of HCV infection correlates with cure of vasculitis …
of regulatory T cells (Tregs). Resolution of HCV infection correlates with cure of vasculitis …
Natural regulatory T cells control the development of atherosclerosis in mice
Atherosclerosis is an immunoinflammatory disease elicited by accumulation of lipids in the
artery wall and leads to myocardial infarction and stroke 1 , 2 . Here, we show that naturally …
artery wall and leads to myocardial infarction and stroke 1 , 2 . Here, we show that naturally …
CD4+CD25+ Immunoregulatory T Cells: New Therapeutics for Graft-Versus-Host Disease
JL Cohen, A Trenado, D Vasey, D Klatzmann… - The Journal of …, 2002 - rupress.org
CD4 + CD25 + immunoregulatory T cells play a pivotal role in preventing organ-specific
autoimmune diseases and in tolerance induction to allogeneic organ transplants. We …
autoimmune diseases and in tolerance induction to allogeneic organ transplants. We …
Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State
…, E Litvinova, F Septier, D Klatzmann… - The Journal of …, 2003 - rupress.org
Despite a growing interest in CD4 + CD25 + regulatory T cells (T reg ) that play a major role
in self-tolerance and immunoregulation, fundamental parameters of the biology and …
in self-tolerance and immunoregulation, fundamental parameters of the biology and …
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
D Klatzmann, AK Abbas - Nature Reviews Immunology, 2015 - nature.com
Depletion of regulatory T (T Reg ) cells in otherwise healthy individuals leads to multi-organ
autoimmune disease and inflammation. This indicates that in a normal immune system, …
autoimmune disease and inflammation. This indicates that in a normal immune system, …
[HTML][HTML] Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus …
…, S Fisson, M Yagello, D Klatzmann… - The Journal of …, 2003 - Am Soc Clin Investig
CD4 + CD25 + regulatory T cells (Treg’s) play a pivotal role in preventing organ-specific
autoimmune diseases and in inducing tolerance to allogeneic organ transplants. We and others …
autoimmune diseases and in inducing tolerance to allogeneic organ transplants. We and others …
Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice
…, P Bourin, X Holy, JP Vernant, D Klatzmann… - The Journal of …, 2006 - journals.aai.org
Several reports have suggested that mesenchymal stem cells (MSCs) could exert a potent
immunosuppressive effect in vitro, and thus may have a therapeutic potential for T cell-…
immunosuppressive effect in vitro, and thus may have a therapeutic potential for T cell-…